Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients

Expert Review of Clinical Immunology

Volumn 6, Issue 4, 2010, Pages 677-682

  Bernick, Steven J ^a   Kane, Sunanda ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b MAYO CLINIC   (United States)

Author keywords

5 ASA; adherence; compliance; mesalamine; persistence; ulcerative colitis

Indexed keywords

MESALAZINE;

CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE COURSE; DOSAGE SCHEDULE COMPARISON; DRUG COST; HEALTH CARE COST; HUMAN; LONG TERM CARE; PATIENT COMPLIANCE; PRESCRIPTION; REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; HUMANS; MESALAMINE; PATIENT COMPLIANCE; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS;

EID: 77954398317     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.10.28     Document Type: Review

References (31)

1. Hawthorne AB, Rubin G, Ghosh S. Medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalamine and other maintenance therapies. Aliment. Pharmacol. Ther. 27, 1157-1166 (2008). (Pubitemid 351697281)
2. van Hees PA, van Tongeren JH. Compliance to therapy in patients on maintenance dose sulfasalazine. J. Clin. Gastroenterol. 4(4), 333-336 (1982). (Pubitemid 12098750)
3. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am. J. Gastroenterol. 114, 39-134 (2003). (Pubitemid 36126514)
4. Lee M, Kemp JA, Canning A et al. A randomized controlled trial of enhanced patient compliance program for Helicobacter pylori therapy. Arch. Intern. Med. 159, 2312-2316 (1999). (Pubitemid 29501531)
5. Robinson A. Review article: improving adherence to medication in patients with infammatory bowel disease. Aliment. Pharmacol. Ther. 27(Suppl. 1), 9-14 (2008). (Pubitemid 351328756)
6. Lakatos P. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it. World J. Gastroenterol. 15, 4234-4239 (2009).
7. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig. Dis. Sci. 53(4), 1020-1024 (2008). (Pubitemid 351379831)
8. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment. Pharmacol. Ther. 23, 577-585 (2006).
9. Rubin DT, Siegel CA, Kane SV. The impact of ulcerative colitis from patients' and physicians' perspective: results from the UC: NORMAL survey. Infamm. Bowel Dis. 15, 581-588 (2009).
10. Kane SV, Cohen RD, Aikens JEB. Predictors of non-compliance with mesalamine in quiescent ulcerative colitis. Am. J. Gastroenterol. 96, 2929-2932 (2001).
11. Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am. J. Gastroenterol. 94, 1733-1742 (1999).
12. Nigro G, Angelini G, Grosso SB, Caula G, Sategna-Guidetti C. Psychiatric predictors of noncompliance in infammatory bowel disease: psychiatry and compliance. J. Clin. Gastroenterol. 32(1), 66-68 (2001). (Pubitemid 32038115)
13. Kane S, Accortt N, Magowan S, Brixner D. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Aliment. Pharmacol. Ther. 29, 855-862 (2009).
14. Kane S, Sumner M, Solomon D, Jenkins M. Continuing persistence with mesalamine therapy: results from patients persistent with long-term therapy. Am. J. Gastroenterol. 104(Suppl. 3), A1271 (2009).
15. Kane S, Sumner M, Solomon D, Jenkins M. Factors affecting persistence with mesalamine therapy: results from a large pharmacy database. Am. J. Gastroenterol 104(Suppl. 3), A1272 (2009).
16. Traynor K. Standards-setting group seeks to improve medication adherence. Am. J. Health Syst. Pharm. 62, 2440-2442 (2005). (Pubitemid 41720556)
17. Prochaska JO, DiClemente CC. Stages of change in the modifcation of problem behaviors. Prog. Behav. Modif. 28, 183-218 (1992).
18. Tindall W, Boltri J, Wilhelp S. Mild-to-moderate ulcerative colitis: your role in patient compliance and health care costs. J. Manag Care Pharm. 13, S1-S12 (2007).
19. Stewart MA. What is a successful doctor patient interview? A study of interactions and outcomes. Soc. Sci. Med. 19, 167-175 (1984).
20. Fallowfeld L, Jenkins V, Farewell V et al. Effcacy of a communication skills training model for oncologists: a randomized controlled trial. Lancet 359, 650-656 (2002). (Pubitemid 34203764)
21. Morse DS, Edwardsen EA, Gordon HS. Missed opportunities for interval empathy in lung cancer communication. Arch. Intern. Med. 168, 1853-1858 (2008).
22. Robinson A, Thompson DG, Wilkin D et al. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomized trial. Lancet 358(9268), 976-981 (2001). (Pubitemid 32913524)
23. Tukey M, Flachuk K, Cheifetz A, Moss A. A patient support program (PSP) to enhance medication adherence and quality-of-life in patients prescribed mesalamine for ulcerative colitis-a pilot study. Am. J. Gastroenterol. 73(Suppl.), A288 (2008).
24. Dignass A, Bokemeyer B, Ademek H et al. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Clin. Gastroenterol Hepatol. 7, 762-769 (2009).
25. Prantera C, Viscido A, Biancone L et al. A new oral delivery system for 5-ASA: preliminary clinical fndings for MMX. Infamm. Bowel Dis. 11, 421-427 (2005). (Pubitemid 40704075)
26. Gray J, Leung E, Scales J. Treatment of ulcerative colitis from the patient's perspective: a survey of preferences and satisfaction with therapy. Aliment. Pharmacol. Ther. 29, 1114-1120 (2009).
27. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fll rates in seniors with hypertension. Am. J. Manag. Care 15(1), 59-66 (2009).
28. Scherman MH, Lowhagen O. Drug compliance and identity: reasons for non-compliance. Experiences of medication from persons with asthma/allergy. Patient Educ. Couns. 54, 3-9 (2004). (Pubitemid 38798332)
29. Yen EF, Kane SV, Ladabaum U. Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis. Am. J. Gastroenterol. 103, 3094-3105 (2008).
30. Higgins PD, Rubin DT, Kaulback K, Schoenfeld PS, Kane SV. Systematic review: impact of non-adherence to 5-ASA products on the frequency and cost of ulcerative colitis fares. Aliment. Pharmacol. Ther. 29(3), 247-257 (2009).
31. Morisky DE, Alfonso A, Krousel-Wood M et al. Predicitve validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. 10, 348-354 (2008). (Pubitemid 41376780)